Bladder Transitional Cell Carcinoma Stage IV
1 clinical trials · Condition
◉ Watch Bladder Transitional Cell Carcinoma Stage IV
| Record | Firm | Date |
|---|---|---|
| JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin (NCT01599013) | Pierre Fabre Medicament | 2011-02-01 |
Track Bladder Transitional Cell Carcinoma Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.